While pharmaceutical commercial teams navigating the COVID-19 pandemic don’t face the same life-or-death decisions the Apollo 13 team did 50 years ago, they are still responding to rapidly evolving circumstances in an uncertain environment. In Med Ad News, Partner Jon Hesby and Associate Partners Kevin Frymire and Rob Lien share three lessons from the Apollo 13 story that can help pharma companies today.